PMN-MDSCs accumulate in tumour tissues and represent a key adaptive resistance pathway to PD-1 blockade after CD8+ T-cell activation in CXCR2/CXCL5-dependent manners [26]. This evidence concerns the gene CD8A and neoplasm.